Vaginal Microbiome and IVF: What Lactobacillus Dominance May Mean for Implantation

Medically reviewed on 18 July 2026 - Dr. Senai Aksoy
Vaginal Microbiome and IVF: What Lactobacillus Dominance May Mean for Implantation

Key Takeaways

A Lactobacillus-dominant vaginal microbiome may support implantation, while dysbiosis can be associated with inflammation, implantation failure, or chronic endometritis. The evidence is promising but still evolving, so this is not a magic fertility shortcut. When symptoms, recurrent BV, or repeated IVF failure are present, targeted testing and treatment make more sense than self-prescribed probiotics.

Key evidence: ESHRE Good Practice Recommendations on Recurrent Implantation Failure CDC STI Treatment Guidelines — Bacterial Vaginosis Reschini et al. 2022 — endometrial microbiome sampling and assessment

On this page

Vaginal Microbiome and IVF

When IVF fails more than once, patients often look first at embryo quality or endometrial thickness. Those factors matter, but they are not the whole picture. Research now suggests that the vaginal microbiome may also influence inflammation, implantation, and the likelihood of chronic endometritis in some patients.

This does not mean the microbiome is a magic answer for every failed cycle. It means that in selected cases, especially when symptoms, recurrent bacterial vaginosis, or repeated implantation failure are present, the vaginal environment may deserve a closer look.

What a “Healthy” Vaginal Microbiome Usually Means

A healthy vaginal environment is predominantly colonized by protective Lactobacillus species, particularly Lactobacillus crispatus.

Key microbiological patterns:

Why It May Matter for IVF

Vaginal dysbiosis is thought to affect implantation through localized cervical inflammation and immune signaling rather than direct embryo contact.

Proposed physiological pathways:

Is There a Separate Uterine (Endometrial) Microbiome?

The uterine cavity is an anatomically distinct environment from the vagina. Endometrial samples contain significantly fewer total bacteria and rarely mirror vaginal Lactobacillus dominance (Reschini et al. 2022).

Clinical trial findings:

Who May Benefit from Evaluation?

Microbiome evaluation should be targeted rather than routine:

Routine screening before a first, uncomplicated IVF cycle is not indicated.

How to Support a Healthy Vaginal Microbiome

  1. Avoid Irritants: Eliminate vaginal douching, scented wipes, and harsh soaps.
  2. Targeted Antimicrobials: Use antibiotics or antifungals strictly when clinical infection is diagnosed.
  3. Probiotic Strategy: Discuss oral or vaginal probiotics as supportive measures, acknowledging limited evidence for direct IVF yield enhancement (CDC 2021 Guidelines).
  4. Avoid Unproven Home Remedies: Never apply food products (such as yogurt) vaginally.

Dr. Aksoy’s Clinical Perspective:
“Lactobacillus is protective in the vagina, but treating a low reading with probiotics is not a simple vitamin fix. Active bacterial vaginosis requires antibiotics, not probiotics. Furthermore, the uterine cavity is a distinct environment with far fewer bacteria. Reaching a specific endometrial Lactobacillus percentage is not a standard IVF target. I treat diagnosed clinical conditions and the patient in front of me—not a commercial microbiome score.”

Request a Case Review

If you have recurrent bacterial vaginosis, repeated implantation failure, or are wondering whether a vaginal or endometrial microbiome finding is relevant to your case, a structured review of your history and prior test results is a more useful starting point than a standalone microbiome panel. You can request a confidential case review to have your file assessed before deciding on next steps.

Clinical Note

A healthy, Lactobacillus-dominant vaginal microbiome supports an optimal uterine environment for embryo transfer.

However, routine microbiome testing for every IVF patient is not currently recommended by guidelines.

When dysbiosis or chronic endometritis is suspected, targeted evaluation and treatment should be individualized.

Dr. Senai Aksoy

FAQ

Should every IVF patient test the vaginal microbiome?

No. Routine testing for every patient is not currently supported by strong enough evidence. It is more relevant in selected clinical situations.

Is Lactobacillus crispatus always “good”?

It is generally considered a favorable sign because it is associated with a more stable, acidic vaginal environment. But a single microbiome result should still be interpreted together with symptoms and fertility history.

Can probiotics improve IVF success?

Possibly in selected cases, but they are not a guaranteed fertility treatment. Probiotics should not replace diagnosis and targeted treatment when infection or inflammation is suspected.

Persistent dysbiosis may contribute to an inflammatory environment and is sometimes associated with chronic endometritis, especially in patients with recurrent implantation failure or unexplained infertility.

Should antibiotics be used before every embryo transfer?

No. Antibiotics should be used when there is evidence of infection or another specific indication. Routine, blind use is not a good strategy.

Sources

Next step

A question about your own case?

An article can set out the general picture, but not what applies to your own history. If you would like your situation looked at, you can send your questions and any previous reports to the medical team.

Request a medical review

Add as a Preferred Source on Google

You can add draksoyivf.com as one of your preferred health information sources on Google.

Add on Google
Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.